CD163 and myeloid sarcoma: Besides, the percentages of CD163+CD11b+ (HGC27: p = 0.040; MKN45: p = 0.029) and CD206+CD11b+ cells (HGC27: p = 0.016; MKN45: p = 0.039) (M2 macrophages) were increased in MS and MR cells, and the percentage was higher in MR cells than in MS cells (Fig. 3D).